Grey Street Capital »

Rxsight shares owned by Grey Street Capital

Quarter-by-quarter ownership of Rxsight (RXST) shares owned by Grey Street Capital from 13F filings

Historical chart of Grey Street Capital investment in Rxsight

Tip: Access up to 7 years of quarterly data

All positions including Rxsight held by Grey Street Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rxsight by Grey Street Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $978k 19k 51.58
2023-12-31 $765k 19k 40.32

More positions owned by Grey Street Capital

NVIDIA Corporation (NVDA)
Eli Lilly & Co. (LLY)
Accenture Plc Ireland Shs Class A (ACN)
Microsoft Corporation (MSFT)
Apple (AAPL)
Vertex Pharmaceuticals Incorporated (VRTX)
Meta Platforms Cl A (META)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Crowdstrike Hldgs Cl A (CRWD)
Adobe Systems Incorporated (ADBE)
Goldman Sachs (GS)
Agnico (AEM)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Grey Street Capital

Top funds holding Rxsight

RA Capital Management
BlackRock
BlackRock
Vanguard Group
Lord, Abbett & Co
Artisan Partners Limited Partnership
Morgan Stanley
Invesco
Geode Capital Management
State Street Corporation
Bank of America Corporation
Driehaus Capital Management
Deutsche Bank Aktiengesellschaft
Nuveen Asset Management
Brown Capital Management

View all funds holding Rxsight